Noel G. Mc Elvaney

Dr. McElvaney is Professor of Medicine, Royal College of Surgeons in Ireland (RCSI), and consultant in Pulmonary & General Internal Medicine. Professor McElvaney has a strong track record in translational research and has published widely in the areas of cystic fibrosis (CF), alpha-1 antitrypsin deficiency (AATD), infection, immunity, and lung inflammation.

His area of clinical practice is respiratory diseases, and his areas of special expertise is respiratory medicine. Professor McElvaney founded the Alpha One Foundation of Ireland and received funding from the Department of Health and Children to establish the first national targeted detection program for AATD in Europe. This genetic condition is associated with risk for severe lung, liver, and skin diseases. He also set up the cystic fibrosis service in Beaumont Hospital, which is now the Health Service Executive (HSE)-designated Dublin CF center. Following graduation at the University College, Dublin, and training in the Mater University Hospital, Dublin, Professor McElvaney pursued specialist training in Vancouver, Canada, the National Institutes of Health, Bethesda, MD, and Cornell University in New York. He returned to Ireland in 1996 to take up positions at the RCSI and Beaumont Hospital. He was appointed Professor of Medicine RCSI, and has over 30 years of experience in lung medicine and over 300 publications, particularly in the areas of AATD and cystic fibrosis.